LightPath Technologies (LPTH)
Builds optics, infrared assemblies, and imaging systems for defense and commercial applications.
$9.95
vs last close−0.26 (−2.50%)
In millions of USD, except per-share figures
| In millions | Q1 FY24Sep 2023 | Q2 FY24Dec 2023 | Q3 FY24Mar 2024 | Q4 FY24Jun 2024 | Q1 FY25Sep 2024 | Q2 FY25Dec 2024 | Q3 FY25Mar 2025 | Q4 FY25Jun 2025 | Q1 FY26Sep 2025 | Q2 FY26Dec 2025 | Q3 FY26Mar 2026 | Q4 FY26Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8 | 7 | 8 | 9 | 8 | 7 | 9 | 12 | 15 | 16 | 19 | 21 |
| Cost of revenue | 6 | 5 | 6 | 6 | 6 | 5 | 7 | 10 | 11 | 10 | 12 | 13 |
| Gross profit | 2 | 2 | 2 | 3 | 3 | 2 | 3 | 3 | 4 | 6 | 7 | 8 |
| 4 | 4 | 4 | 5 | 4 | 4 | 6 | 7 | 7 | 7 | 8 | 13 | |
| Research & development | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 258,551 |
| Selling, general & administrative | 0 | 3 | 0 | 0 | 0 | 3 | 0 | 0 | 4 | 6 | 6 | 3,737,020 |
| Other expenses | 3 | 0 | 4 | 4 | 4 | 0 | 5 | 6 | 2 | 0 | 0 | −3,995,559 |
| Operating income | −1 | −2 | −3 | −2 | −1 | −2 | −3 | −5 | −3 | −1 | −1 | 3 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | −3 | 0 | −8 | −3 | −7 | |
| Interest income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 |
| Other non-operating income | 0 | 0 | 0 | −1 | 0 | 0 | 0 | −3 | 0 | 8 | 0 | 0 |
| Income before tax | −1 | −2 | −3 | −2 | −2 | −3 | −3 | −7 | −3 | −9 | −4 | −4 |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | −1 | −2 | −3 | −2 | −2 | −3 | −4 | −7 | −3 | −9 | −4 | −4 |
| Net income | −1 | −2 | −3 | −2 | −2 | −3 | −4 | −7 | −3 | −9 | −4 | −4 |
| EPS, basic | −$0.04 | −$0.05 | −$0.07 | −$0.06 | −$0.04 | −$0.07 | −$0.09 | −$0.16 | −$0.07 | −$0.20 | −$0.07 | −$0.06 |
| EPS, diluted | −$0.04 | −$0.05 | −$0.07 | −$0.06 | −$0.04 | −$0.07 | −$0.09 | −$0.17 | −$0.07 | −$0.20 | −$0.07 | −$0.06 |
| Weighted average shares, basic | 37 | 38 | 38 | 38 | 40 | 40 | 41 | 43 | 43 | 47 | 59 | 53 |
| Weighted average shares, diluted | 37 | 38 | 38 | 39 | 40 | 40 | 41 | 43 | 43 | 47 | 59 | 53 |
| EBITDA | 0 | 0 | −2 | 0 | 0 | −1 | −2 | −1 | −1 | −8 | 0 | 0 |
| Depreciation & amortization | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBIT | −1 | −2 | −3 | −1 | −1 | −2 | −3 | −2 | −3 | −9 | −1 | −1 |